That other beta cell product
GLP-1
+3

Jul 2, 2026
•
14 min read
Orals, Triples, Biologics and even more data from ADA 2026
GLP-1
+4

Jul 1, 2026
•
5 min read
New phase 1b data shows incredible weight loss
GLP-1
+2

Jun 19, 2026
•
18 min read
A tale of dual agonists, glucagon or amylin, who wins the insulin sensitivity race?
GLP-1
+6

May 29, 2026
•
10 min read
The Super Bowl Conference for diabetes and incretins!
GLP-1
+2

Mar 11, 2026
•
11 min read
More early trial results from some new players in the obesity medicine space

A collection of collated data on incretin drug developments, including new drugs, new treatments and the future of incretin in medicine